The new medical challenge: why NDM-1? Why Indian?

Expert Rev Anti Infect Ther. 2011 Feb;9(2):137-41. doi: 10.1586/eri.10.159.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Carbapenems / pharmacology
  • Drug Resistance, Multiple, Bacterial* / genetics
  • Enterobacteriaceae / drug effects*
  • Enterobacteriaceae / genetics
  • Enterobacteriaceae Infections / epidemiology*
  • Enterobacteriaceae Infections / microbiology
  • Humans
  • India / epidemiology
  • Microbial Sensitivity Tests
  • beta-Lactamases / biosynthesis*
  • beta-Lactamases / genetics

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • beta-Lactamases
  • beta-lactamase NDM-1